Targeting iron metabolism in drug discovery and delivery

Cites (352)

Items 201–353 of 353

1. A Novel Model for Brain Iron Uptake: Introducing the Concept of Regulation
   Ian A. Simpson, Padmavathi Ponnuru, Marianne Klinger, Roland L. Myers, Kavi Devraj, Christopher L. Coe, Gabriele R. Lubach, Anthony Carruthers, James R. Connor · 2014 · Journal of Cerebral Blood Flow & Metabolism
2. Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin
   Wilfred Arthur Jefferies, Michael R. Food, Reinhard Gabathuler, Sylvia Rothenberger, Tatsuo Yamada, Osamu Yasuhara, Patrick L. McGeer · 1996 · Brain Research
3. Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163
   Anders Etzerodt, Maciej Bogdan Maniecki, Jonas Heilskov Graversen, Holger Jon Møller, Vladimir P. Torchilin, Søren K. Moestrup · 2012 · Journal of Controlled Release
4. Transferrin Receptor 2 Is Frequently and Highly Expressed in Glioblastomas
   Alessia Calzolari, Luigi Maria Larocca, Silvia Deaglio, Veronica Finisguerra, Alessandra Boe, Carla Raggi, Lucia Ricci-Vitani, Francesco Pierconti, Fabio Malavasi, Ruggero D. Maria et al. · 2010 · Translational Oncology
5. The Fowler Syndrome-Associated Protein FLVCR2 Is an Importer of Heme
   Simon P. Duffy, Jennifer C. Shing, Punit Saraon, Lloyd Berger, Maribeth V. Eiden, Andrew Wilde, Chetankumar S. Tailor · 2010 · Molecular and Cellular Biology
6. Regulated secretion of glycosylated human ferritin from hepatocytes
   Sharmistha Ghosh, Sarah Hevi, Steven L. Chuck · 2003 · Blood
7. Disordered hepcidin–ferroportin signaling promotes breast cancer growth
   Shuping Zhang, Yue Chen, Wenli Guo, Lin Yuan, Daoqiang Zhang, Yong Xu, Elizabeta Nemeth, Tomas Ganz, Sijin Liu · 2014 · Cellular Signalling
8. Phenotypic profile of alternative activation marker CD163 is different in Alzheimer’s and Parkinson’s disease
   Pey, Peixuan, Pearce, Ronald KB, Kalaitzakis, Michail E, Griffin, W Sue T, Gentleman, Steve M · 2014 · Acta Neuropathologica Communications
9. Cellular protection using Flt3 and PI3Kα inhibitors demonstrates multiple mechanisms of oxidative glutamate toxicity
   Yunyi Kang, Stefano Tiziani, Goonho Park, Marcus Kaul, Giovanni Paternostro · 2014 · Nature Communications
10. Parenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains
    Zhiren Zhang, Zhiyuan Zhang, Jens Schittenhelm, Yuzhang Wu, Richard Meyermann, Hermann J. Schluesener · 2011 · Journal of Neuroimmunology
11. Regulation of TMPRSS6 by BMP6 and iron in human cells and mice
    Delphine Meynard, Valentina Vaja, Chia Chi Sun, Elena Corradini, Shanzhuo Chen, Carlos López-Otı́n, Lovorka Grgurević, Charles C. Hong, Marit Stirnberg, Michael Gütschow et al. · 2011 · Blood
12. -thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies
    Stefano Rivella · 2015 · Haematologica
13. Iron activates NF-κB in Kupffer cells
    She, Hongyun, Xiong, Shigang, Lin, Min, Zandi, Ebrahim, Giulivi, Cecilia, Tsukamoto, Hidekazu · 2002 · American Journal of Physiology-Gastrointestinal and Liver Physiology
14. Outward- and inward-facing structures of a putative bacterial transition-metal transporter with homology to ferroportin
    Taniguchi, Reiya, Kato, Hideaki E., Font, Josep, Deshpande, Chandrika N., Wada, Miki, Ito, Koichi, Ishitani, Ryuichiro, Jormakka, Mika, Nureki, Osamu · 2015 · Nature Communications
15. Macular Degeneration in a Patient with Aceruloplasminemia, a Disease Associated with Retinal Iron Overload
    Joshua L. Dunaief, Carine Ghassan Richa, Edward P. Franks, Robert L. Schultze, Tomás S. Alemán, John F. Schenck, Earl A. Zimmerman, D BROOKS · 2005 · Ophthalmology
16. Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences
    Xinsheng Wang, Sang Yong Lee, Zachary Simmons, Philip J. Boyer, Kevin R. Scott, Wenlei Liu, James R. Connor · 2004 · Journal of the Neurological Sciences
17. Distribution of transferrin and ferritin binding in normal and multiple sclerotic human brains
    Stanley W. Hulet, S K Powers, James R. Connor · 1999 · Journal of the Neurological Sciences
18. Targeted tumor delivery and controlled release of neuronal drugs with ferritin nanoparticles to regulate pancreatic cancer progression
    Yifeng Lei, Yoh Hamada, Jun Li, Liman Cong, Nuoxin Wang, Ying Li, Wenfu Zheng, Xingyu Jiang · 2016 · Journal of Controlled Release
19. A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates
    Cooke, Keegan S., Hinkle, Beth, Salimi-Moosavi, Hossein, Foltz, Ian, King, Chadwick, Rathanaswami, Palaniswami, Winters, Aaron, Steavenson, Shirley, Begley, C. Glenn, Molineux, Graham et al. · 2013 · Blood
20. Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice
    Canali, Susanna, Core, Amanda B., Zumbrennen-Bullough, Kimberly B., Merkulova, Maria, Wang, Chia-Yu, Schneyer, Alan L., Pietrangelo, Antonello, Babitt, Jodie L. · 2016 · Endocrinology
21. Repulsive guidance molecule is a structural bridge between neogenin and bone morphogenetic protein
    Healey, Eleanor G, Bishop, Benjamin, Elegheert, Jonathan, Bell, Christian H, Padilla-Parra, Sergi, Siebold, Christian · 2015 · Nature Structural & Molecular Biology
22. Transferrin receptor regulates pancreatic cancer growth by modulating mitochondrial respiration and ROS generation
    Seung Min Jeong, Sunsook Hwang, Rho Hyun Seong · 2016 · Biochemical and Biophysical Research Communications
23. Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans
    van Eijk, Lucas T., John, Aaron S. E., Schwoebel, Frank, Summo, Luciana, Vauléon, Stéphanie, Zöllner, Stefan, Laarakkers, Coby M., Kox, Matthijs, van der Hoeven, Johannes G., Swinkels, Dorine W. et al. · 2014 · Blood
24. Molecular mechanisms of non‐transferrin‐bound and transferring‐bound iron uptake in primary hippocampal neurons
    Changyi Ji, Daniel J. Kosman · 2015 · Journal of Neurochemistry
25. Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome.
    J E Nielsen, L N Jensen, K. S. Krabbe · 1995 · Journal of Neurology Neurosurgery & Psychiatry
26. Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus
    Gardenghi, Sara, Renaud, Tom M., Meloni, Alessandra, Casu, Carla, Crielaard, Bart J., Bystrom, Laura M., Greenberg-Kushnir, Noa, Sasu, Barbra J., Cooke, Keegan S., Rivella, Stefano · 2014 · Blood
27. Iron and Neurodegeneration: Is Ferritinophagy the Link?
    Giorgio Biasiotto, Diego Di Lorenzo, Silvana Archetti, Isabella Zanella · 2015 · Molecular Neurobiology
28. Transferrin-mediated fullerenes nanoparticles as Fe2+-dependent drug vehicles for synergistic anti-tumor efficacy
    Huijuan Zhang, Lin Hou, Yandan Ji, Yandan Ji, Xiali Zhu, Zhenzhong Zhang · 2014 · Biomaterials
29. Probing the substrate specificities of matriptase, matriptase‐2, hepsin and DESC1 with internally quenched fluorescent peptides
    François Béliveau, Antoine Désilets, Richard Leduc · 2009 · FEBS Journal
30. Mutations in the hemochromatosis gene (HFE), Parkinson's disease and parkinsonism.
    M. Dekker, P. C. Giesbergen, O. Njajou, J. V. van Swieten, A. Hofman, M. Breteler, C. M. van Duijn · 2003 · Neuroscience Letters
31. A novel gene expression signature for bone metastasis in breast carcinomas
    Cemile Dilara Savci-Heijink, Hans Halfwerk, Jan Köster, Marc J. van de Vijver · 2016 · Breast Cancer Research and Treatment
32. Mechanisms and regulation of iron trafficking across the capillary endothelial cells of the blood-brain barrier
    Ryan C. McCarthy, Daniel J. Kosman · 2015 · Frontiers in Molecular Neuroscience
33. Targeted deletion of the mouse Mitoferrin1 gene: from anemia to protoporphyria
    Troadec, Marie-Berengere, Warner, David, Wallace, Jared, Thomas, Kirk, Spangrude, Gerald J., Phillips, John, Khalimonchuk, Oleh, Paw, Barry H., Ward, Diane McVey, Kaplan, Jerry · 2011 · Blood
34. Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice
    Nai, Antonella, Rubio, Aude, Campanella, Alessandro, Gourbeyre, Ophélie, Artuso, Irene, Bordini, Jessica, Gineste, Aurélie, Latour, Chloé, Besson-Fournier, Céline, Lin, Herbert Y. et al. · 2016 · Blood
35. Secreted Factors from Colorectal and Prostate Cancer Cells Skew the Immune Response in Opposite Directions
    Marie Lundholm, Christina Hägglöf, Maria L. Wikberg, Pär E. Stattin, Lars Egevad, Anders R. J. Bergh, Pernilla Wikström, Richard Palmqvist, Sofia Edin · 2015 · Scientific Reports
36. Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6‐OHDA‐lesioned rats
    Jun Wang, Hong Fu Jiang, Junxia Xie · 2007 · European Journal of Neuroscience
37. Prion Protein Regulates Iron Transport by Functioning as a Ferrireductase
    Ajay Singh, Swati Haldar, Katharine Horback, Cynthia M. Tom, Lan Zhou, Howard J. Meyerson, Neena Singh · 2013 · Journal of Alzheimer s Disease
38. Heterozygous Mutations in BMP6 Pro-peptide Lead to Inappropriate Hepcidin Synthesis and Moderate Iron Overload in Humans
    Raêd Daher, Caroline Kannengiesser, Dounia Houamel, Thibaud Lefèbvre, Edouard Bardou‐Jacquet, Nicolas Ducrot, Caroline de Kerguenec, Anne‐Marie Jouanolle, Anne-Marie Robréau, Claire Oudin et al. · 2015 · Gastroenterology
39. Abnormal Brain Iron Homeostasis in Human and Animal Prion Disorders
    Ajay Vikram Singh, Alfred Orina Isaac, Xiu Luo, Maradumane L. Mohan, Mark L. Cohen, Fusong Chen, Qingzhong Kong, Jason C. Bartz, Neena Singh · 2009 · PLoS Pathogens
40. Liver X Receptor Activation Stimulates Iron Export in Human Alternative Macrophages
    Gael F. P. Bories, Sophie Colin, Jonathan Vanhoutte, Bruno Derudas, Corinne Copin, Mélanie Fanchon, Mehdi Daoudi, Loïc Belloy, Stéphan Haulon, Christophe Zawadzki et al. · 2013 · Circulation Research
41. Transferrin receptor-independent uptake of differic transferrin by human hepatoma cells with antisense inhibition of receptor expression
    Deborah Trinder · 1996 · Hepatology
42. Local iron homeostasis in the breast ductal carcinoma microenvironment
    Marques, Oriana, Porto, Graça, Rêma, Alexandra, Faria, Fátima, Cruz Paula, Arnaud, Gomez-Lazaro, Maria, Silva, Paula, Martins da Silva, Berta, Lopes, Carlos · 2016 · BMC Cancer
43. Isoform-Selective and Stereoselective Inhibition of Hypoxia Inducible Factor-2
    Thomas H. Scheuermann, Daniel Stroud, Christopher E. Sleet, Liela Bayeh, Cameron Shokri, Hanzhi Wang, Charles G. Caldwell, Jamie C. Longgood, John B. MacMillan, Richard K. Bruick et al. · 2015 · Journal of Medicinal Chemistry
44. ‘Ride on the ferrous wheel’ – The cycle of iron in macrophages in health and disease
    Nairz, Manfred, Schroll, Andrea, Demetz, Egon, Tancevski, Ivan, Theurl, Igor, Weiss, Günter · 2015 · Immunobiology
45. Cancer cells with irons in the fire
    Laura M. Bystrom, Stefano Rivella · 2014 · Free Radical Biology and Medicine
46. Beyond hereditary hemochromatosis: New insights into the relationship between iron overload and chronic liver diseases
    Silvia Rossana Fargion, Luca V. C. Valenti, Anna Ludovica Fracanzani · 2010 · Digestive and Liver Disease
47. Transferrin receptors of rat and human brain and cerebral microvessels and their status in Alzheimer's disease
    Raj N. Kalaria, Susan M. Sromek, I. Grahovac, Sami I. Harik · 1992 · Brain Research
48. Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients
    Steven M. LeVine, SHARON G. LYNCH, Ching‐Nan Ou, Michael J Wulser, Estella Tam, Nicole Boo · 1999 · Brain Research
49. Transferrin Receptor–Independent Uptake of Differic Transferrin by Human Hepatoma Cells With Antisense Inhibition of Receptor Expression
    Deborah Trinder, Olga Zak, P Aisen · 1996 · Hepatology
50. Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells
    Simonetta Geninatti Crich, Marta Cadenazzi, Stefania Lanzardo, Laura Conti, Roberto Ruiu, Diego Alberti, Federica Cavallo, Juan Carlos Cutrìn, Silvio Aime · 2015 · Nanoscale
51. Hepcidin Destabilizes Atherosclerotic Plaque Via Overactivating Macrophages After Erythrophagocytosis
    Jing Jing Li, Xiao Meng, Hai Sen Peng, Cheng Zhang, Hui Xia Lv, Yu Xia Zhao, Jian Min Yang, Mei Dong, Kai Zhang, Su Xia Liu et al. · 2012 · Arteriosclerosis Thrombosis and Vascular Biology
52. Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis
    Wallace, Daniel F., Clark, Roslyn M., Harley, Hugh A.J., Subramaniam, V.Nathan · 2004 · Journal of Hepatology
53. Stromal cell-derived receptor 2 and cytochrome b561 are functional ferric reductases
    Juan Daniel Hernández Vargas, Bram Herpers, Andrew Tristan McKie, Sarah Gledhill, James M. McDonnell, M. van den Heuvel, K E Davies, Chris Paul Ponting · 2003 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
54. Small-Molecule Screening Identifies the Selanazal Drug Ebselen as a Potent Inhibitor of DMT1-Mediated Iron Uptake
    Herbert A. Wetli, Peter D. Buckett, Marianne Wessling‐Resnick · 2006 · Chemistry & Biology
55. Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation
    Juan Guillermo Zarruk, Jennifer L. Berard, Rosmarini Passos dos Santos, Antje Kroner, Jaekwon Lee, Paolo Arosio, Samuel David · 2015 · Neurobiology of Disease
56. Prion protein functions as a ferrireductase partner for ZIP14 and DMT1
    Ajai K. Tripathi, Swati Haldar, Juan Qian, Amber Beserra, Srinivas Suda, Ajay Vikram Singh, Ulrich Hopfer, Shu G. Chen, Michael D. Garrick, Jerrold R. Turner et al. · 2015 · Free Radical Biology and Medicine
57. Safety, pharmacokinetics and pharmacodynamics of the anti‐hepcidin Spiegelmer lexaptepid pegol in healthy subjects
    Malcolm J. Boyce, Steve Warrington, B Cortezi, Stefan K. Zöllner, Stephanie Vauléon, Dorine W. Swinkels, Luciana Summo, Frank Schwoebel, Kai Riecke · 2016 · British Journal of Pharmacology
58. Combination of Tmprss6- ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia
    Carla Casu, Mariam Aghajan, Paraskevi Rea Oikonomidou, Shuling Guo, Brett P. Monia, Stefano Rivella · 2015 · Haematologica
59. High-throughput screening of small molecules identifies hepcidin antagonists
    Fung, Eileen, Sugianto, Priscilla, Hsu, Jason, Damoiseaux, Robert, Ganz, Tomas, Nemeth, Elizabeta · 2013 · Molecular Pharmacology
60. Iron Chelation in Thalassemia Major
    Caterina Borgna‐Pignatti, Maria Marsella · 2015 · Clinical Therapeutics
61. Bmp6 Expression in Murine Liver Non Parenchymal Cells: A Mechanism to Control their High Iron Exporter Activity and Protect Hepatocytes from Iron Overload?
    Marco Rausa, Alessia Pagani, Antonella Nai, Alessandro Campanella, Maria Enrica Gilberti, Pietro Apostoli, Clara Camaschella, Laura Silvestri · 2015 · PLoS ONE
62. The small molecule, genistein, increases hepcidin expression in human hepatocytes
    Zhen, Aileen W., Nguyen, Nancy H., Gibert, Yann, Motola, Shmulik, Buckett, Peter, Wessling-Resnick, Marianne, Fraenkel, Ernest, Fraenkel, Paula G. · 2013 · Hepatology
63. Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer
    Orlandi, R., De Bortoli, M., Ciniselli, C.M., Vaghi, E., Caccia, D., Garrisi, V., Pizzamiglio, S., Veneroni, S., Bonini, C., Agresti, R. et al. · 2014 · Annals of Oncology
64. Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo
    Maura Poli, Michela Asperti, Annamaria Naggi, Natascia Campostrini, Domenico Girelli, Michela Corbella, Marina Benzi, Céline Besson‐Fournier, Hélène Coppin, Federica Maccarinelli et al. · 2014 · Blood
65. Decreased Plasma Iron in Alzheimer’s Disease Is Due to Transferrin Desaturation
    Dominic James Hare, James D. Doecke, Noel Garry Faux, Alan Rembach, Irene Volitakis, Christopher James Fowler, Rudolf Grimm, Philip Doble, Robert A. Cherny, Colin Louis Masters et al. · 2015 · ACS Chemical Neuroscience
66. Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: Preliminary results
    Alberto Donfrancesco, Bruno De Bernardi, Modesto Carli, A. Mancini, M. A. Nigro, Luigi De Sio, Fiorina Casale, Serenella Bagnulo, Lawrence Helson, G Deb · 1995 · European Journal of Cancer
67. Subcellular Localization of Iron and Heme Metabolism Related Proteins at Early Stages of Erythrophagocytosis
    Constance Delaby, Christiane Rondeau, Cécile Pouzet, Alexandra Willemetz, Nathalie Pilard, Michel Desjardins, François Canonne‐Hergaux · 2012 · PLoS ONE
68. Overexpression of Transferrin Receptor and Ferritin Related to Clinical Symptoms and Destabilization of Human Carotid Plaques
    Li, Wei, Xu, Li-Hua, Forssell, Claes, Sullivan, Jerome L., Yuan, Xi-Ming · 2008 · Experimental Biology and Medicine
69. Dose‐Dependent Therapeutic Distinction between Active and Passive Targeting Revealed Using Transferrin‐Coated PGMA Nanoparticles
    Ruhani Singh, Marck Nörret, Michael J. House, Yuriy Galabura, Michael Bradshaw, Diwei Ho, Robert C. Woodward, Timothy G. St. Pierre, Igor A. Luzinov, Nicole M. Smith et al. · 2015 · Small
70. Identification of the First Low-Molecular-Weight Inhibitors of Matriptase-2
    Mihiret T. Sisay, Torsten Steinmetzer, Marit Stirnberg, Eva Maurer, Maya Hammami, Jürgen Bajorath, Michael Gütschow · 2010 · Journal of Medicinal Chemistry
71. Differing impact of the deletion of hemochromatosis‐associated molecules HFE and transferrin receptor‐2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin
    Chloé Latour, Céline Besson‐Fournier, Delphine Meynard, Laura Silvestri, Ophélie Gourbeyre, Patricia Aguilar‐Martinez, Paul Joseph Schmidt, Mark D. Fleming, Marie‐Paule Roth, Hélène Coppin · 2015 · Hepatology
72. Structure of the Repulsive Guidance Molecule (RGM)–Neogenin Signaling Hub
    Bell, Christian H., Healey, Eleanor, van Erp, Susan, Bishop, Benjamin, Tang, Chenxiang, Gilbert, Robert J.C., Aricescu, A. Radu, Pasterkamp, R. Jeroen, Siebold, Christian · 2013 · Science
73. Iron-sulfur proteins hiding in plain sight
    Tracey Ann Rouault · 2015 · Nature Chemical Biology
74. Divalent metal transporter 1 is a hypoxia‐inducible gene
    Zhong‐Ming Qian, Xiao Mei Wu, Ming Fan, Lin Yang, Fang Du, Wing‐Ho Yung, Ya Ke · 2010 · Journal of Cellular Physiology
75. Expression and cellular localization of hepcidin mRNA and protein in normal rat brain
    Ruma Raha‐Chowdhury, Animesh Alexander Raha, Serhiy Forostyak, Jingwei Zhao, Simon Stott, Adrian B. Bomford · 2015 · BMC Neuroscience
76. Structure-Function Analysis of the Human Ferroportin Iron Exporter (SLC40A1): Effect of Hemochromatosis Type 4 Disease Mutations and Identification of Critical Residues
    Gérald Le Gac, Chandran Ka, Rozenn Joubrel, Isabelle Gourlaouen, Pierre Lehn, Jean‐Paul Mornon, Claude Férec, Isabelle Callebaut · 2013 · Human Mutation
77. Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence inβ-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial
    John B. Porter, Donald K. Bowden, Marina P. Economou, Jacques Troncy, Arnold Ganser, Dany Habr, Nicholas G. Martin, Adam Gater, Diana Rofail, Linda Abetz‐Webb et al. · 2012 · Anemia
78. Regulation of ATP13A2 via PHD2-HIF1α Signaling Is Critical for Cellular Iron Homeostasis: Implications for Parkinson's Disease
    Subramanian Rajagopalan, Anand Rane, Shankar J. Chinta, Julie Kay Andersen · 2016 · Journal of Neuroscience
79. Ferritin Is Independently Associated With the Presence of Coronary Artery Calcium in 12 033 Men
    Ki‐Chul Sung, Seok‐Min Kang, Eun-Joo Cho, Jeong Bae Park, Sarah H. Wild, Christopher D. Byrne · 2012 · Arteriosclerosis Thrombosis and Vascular Biology
80. Duodenal Reductase Activity and Spleen Iron Stores Are Reduced and Erythropoiesis Is Abnormal in Dcytb Knockout Mice Exposed to Hypoxic Conditions3
    Jeehyea Choi, Patarabutr Masaratana, Gladys Oluyemisi Latunde-Dada, Matthew J Arno, Robert James Simpson, Andrew Tristan McKie · 2012 · Journal of Nutrition
81. Age-related changes of brain iron load changes in the frontal cortex in APPswe/PS1ΔE9 transgenic mouse model of Alzheimer's disease
    Xianhui Dong, Weijuan Gao, Tie-mei Shao, Xie Hong-lin, Bai Jiang-tao, Zhao Jing-yi, Chai Xi-qing · 2014 · Journal of Trace Elements in Medicine and Biology
82. Myeloid zinc-finger 1 (MZF-1) suppresses prostate tumor growth through enforcing ferroportin-conducted iron egress
    Y Chen, Z Zhang, Kuo Yang, Jin Du, Yong Xu, Sijin Liu · 2014 · Oncogene
83. A novel type of congenital hypochromic anemia associated with a nonsense mutation in the STEAP3/TSAP6 gene
    Bernard Grandchamp, Gilles Hetet, Caroline Kannengiesser, Claire Oudin, Carole Beaumont, Sylvie Rodrigues-Ferreira, Robert B. Amson, Adam Telerman, Peter Nielsen, ELISABETH KOHNE et al. · 2011 · Blood
84. Natural and synthetic STAT3 inhibitors reduce hepcidin expression in differentiated mouse hepatocytes expressing the active phosphorylated STAT3 form
    Fatih, Nadia, Camberlein, Emilie, Island, Marie Laure, Corlu, Anne, Abgueguen, Emmanuelle, Détivaud, Lénaïck, Leroyer, Patricia, Brissot, Pierre, Loréal, Olivier · 2010 · Journal of Molecular Medicine
85. Iron overload in a murine model of hereditary hemochromatosis is associated with accelerated progression of osteoarthritis under mechanical stress
    António Brito Camacho, Márcio Simão, Hang‐Korng Ea, Martine Esther Cohen-Solal, Pascal Richette, Jaime Branco, M. Leonor Cancela · 2015 · Osteoarthritis and Cartilage
86. Aceruloplasminemia
    Satoshi Kono · 2012 · Current Drug Targets
87. Testing the Iron Hypothesis in a Mouse Model of Atherosclerosis
    Léon Kautz, Victoria R. Gabayan, Xuping Wang, Judy Wu, James Onwuzurike, Grace Jung, Bo Qiao, Aldons Jake Lusis, Tomas Ganz, Elizabeta Nemeth · 2013 · Cell Reports
88. Enhanced alternative splicing of the FLVCR1 gene in Diamond Blackfan anemia disrupts FLVCR1 expression and function that are critical for erythropoiesis
    M. A. Rey, Simon P. Duffy, J. K. Brown, J. A. Kennedy, John Edgar Dick, Yigal Dror, C S Tailor · 2008 · Haematologica
89. Association of K832R and R952K SNPs of Wilson's Disease Gene with Alzheimer's Disease
    Serena Bucossi, Renato A Polimanti, Stefania Mariani, Mariacarla Ventriglia, Cristian Bonvicini, Simone Migliore, Dario Manfellotto, Carlo Salustri, Fabrizio Vernieri, Paolo Maria Rossini et al. · 2012 · Journal of Alzheimer s Disease
90. Iron Deficiency in Parkinsonism: Region-Specific Iron Dysregulation in Parkinson's Disease and Multiple System Atrophy
    Naomi P. Visanji, Joanna F. Collingwood, Mary E. Finnegan, Anurag Tandon, Emily R. House, Lili‐Naz Hazrati · 2013 · Journal of Parkinson s Disease
91. The Small-Molecule Iron Transport Inhibitor Ferristatin/NSC306711 Promotes Degradation of the Transferrin Receptor
    Lior Horonchik, Marianne Wessling‐Resnick · 2008 · Chemistry & Biology
92. Regulation of cell surface transferrin receptor-2 by iron-dependent cleavage and release of a soluble form
    Alessia Pagani, Maud Vieillevoye, Antonella Nai, Marco Rausa, Meriem Ladli, C. Lacombe, Patrick Mayeux, Frédèrique Verdier, Clara Camaschella, Laura Silvestri · 2015 · Haematologica
93. Disordered signaling governing ferroportin transcription favors breast cancer growth
    Yue Chen, Shuping Zhang, Xiaoyan Wang, Wenli Guo, Lei Wang, Daoqiang Zhang, Lin Yuan, Zhihong Zhang, Yong Xu, Sijin Liu · 2014 · Cellular Signalling
94. Distribution of 125I‐Ferrotransferrin Binding Sites in the Mesencephalon of Control Subjects and Patients with Parkinson's Disease
    Baptiste A. Faucheux, Étienne C. Hirsch, João Villares, Fekrije Selimi, Annick Prigent, France Javoy-Agid, Jean‐Jacques Hauw, Yves Agid · 1993 · Journal of Neurochemistry
95. Ferristatin II Promotes Degradation of Transferrin Receptor-1 In Vitro and In Vivo
    Shaina L. Byrne, Peter D. Buckett, Jonghan Kim, Flora Luo, Jack C. Sanford, Juxing Chen, Caroline A. Enns, Marianne Wessling‐Resnick · 2013 · PLoS ONE
96. Higher concentrations of serum iron and transferrin saturation but not serum ferritin are associated with cancer outcomes
    Anita C. G. Chua, Matthew William Knuiman, Debbie Trinder, Mark Divitini, John Kevin Olynyk · 2016 · American Journal of Clinical Nutrition
97. Transferrin receptors in the Parkinsonian midbrain
    Christopher M. Morris, Jeff Candy, S. Omar, C A Bloxham, J.A. Edwardson · 1994 · Neuropathology and Applied Neurobiology
98. Molecular characterization of a third case of human atransferrinemia
    Alexander S. Knisely, Terri Gelbart, Ernest Beutler · 2004 · Blood
99. Human hephaestin expression is not limited to enterocytes of the gastrointestinal tract but is also found in the antrum, the enteric nervous system, and pancreatic β-cells
    David M. Hudson, Susan B. Curtis, Valerie C. Smith, Tanya A. M. Griffiths, Ann Y.K. Wong, Charles H. Scudamore, Alison M. J. Buchan, Ross T. A. MacGillivray · 2009 · American Journal of Physiology-Gastrointestinal and Liver Physiology
100. Serum Hepcidin Is Associated With Presence of Plaque in Postmenopausal Women of a General Population
     Tessel E. Galesloot, Suzanne Holewijn, Lambertus A.L.M. Kiemeney, Jacqueline d Graaf, Sita H. H. M. Vermeulen, Dorine W. Swinkels · 2013 · Arteriosclerosis Thrombosis and Vascular Biology
101. Prion Protein and Metal Interaction: Physiological and Pathological Implications
     Neena Singh, Dola Das, Ajay Vikram Singh, Maradumane L. Mohan · 2010 · Caister Academic Press eBooks
102. Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation‐induced anaemia in rats
     Terrance D. Barrett, Heather L. Palomino, Theresa I. Brondstetter, Kimon C. Kanelakis, Xiaodong Wu, Wen Yan, Katherine P Merton, Freddy Schoetens, Ying Jing, Judy Skaptason et al. · 2015 · British Journal of Pharmacology
103. Ferritin upregulates hepatic expression of bone morphogenetic protein 6 and hepcidin in mice
     Qi Feng, Mary C. Migas, Abdül Waheed, Robert S. Britton, Robert E. Fleming · 2012 · American Journal of Physiology-Gastrointestinal and Liver Physiology
104. Human L-ferritin deficiency is characterized by idiopathic generalized seizures and atypical restless leg syndrome
     Cozzi, Anna, Santambrogio, Paolo, Privitera, Daniela, Broccoli, Vania, Rotundo, Luisa Ida, Garavaglia, Barbara, Benz, Rudolf, Altamura, Sandro, Goede, Jeroen S., Muckenthaler, Martina U. et al. · 2013 · Journal of Experimental Medicine
105. Macrophages and liposomes in inflammatory disease: Friends or foes?
     Bart J. Crielaard, Twan Lammers, Mary E. Morgan, Linda Chaabane, Susanna Carboni, Beatrice Maria Greco, Paola Zaratin, Aletta D. Kraneveld, Gert Storm · 2011 · International Journal of Pharmaceutics
106. Transmembrane Topology of the Mammalian Slc11a2 Iron Transporter
     Maciej Czachorowski, Steven Lam-Yuk-Tseung, Mathieu F. Cellier, Philippe Gros · 2009 · Biochemistry
107. Synthesis and biological evaluation of substituted pyrazoles as blockers of divalent metal transporter 1 (DMT1)
     Jay A. Cadieux, Zaihui Zhang, Maryanne Mattice, Alison Brownlie, Jianmin Fu, Laszlo G. Ratkay, Rainbow Kwan, Jay Thompson, Joseph Sanghara, Jing Zhong et al. · 2011 · Bioorganic & Medicinal Chemistry Letters
108. A mutant light-chain ferritin that causes neurodegeneration has enhanced propensity toward oxidative damage
     Baraibar, Martin A., Barbeito, Ana G., Muhoberac, Barry B., Vidal, Ruben · 2012 · Free Radical Biology and Medicine
109. Carotid intima‐media thickness is increased and related to arterial stiffening in patients with beta‐thalassaemia major
     Yiu‐fai Cheung, PC Chow, Gcf Chan, Sy Ha · 2006 · British Journal of Haematology
110. Do Hemochromatosis Mutations Protect Against Iron-Mediated Atherogenesis?
     Jerome L. Sullivan · 2009 · Circulation Cardiovascular Genetics
111. Human STEAP3 maintains tumor growth under hypoferric condition
     Taichi Isobe, Eishi Baba, Shuji Arita, Masato Komoda, Shingo Tamura, Tsuyoshi Shirakawa, Hiroshi Ariyama, Shigeo Takaishi, Hitoshi Kusaba, Takashi Ueki et al. · 2011 · Experimental Cell Research
112. A Nanoparticulate Ferritin-Core Mimetic Is Well Taken Up by HuTu 80 Duodenal Cells and Its Absorption in Mice Is Regulated by Body Iron
     Gladys Oluyemisi Latunde-Dada, Dora I. A. Pereira, Bethan Tempest, Hibah Ilyas, Angela C. Flynn, Mohamad F. Aslam, Robert James Simpson, Jonathan J. Powell · 2014 · Journal of Nutrition
113. Associations of Serum Ferritin and Transferrin % Saturation With All-cause, Cancer, and Cardiovascular Disease Mortality: Third National Health and Nutrition Examination Survey Follow-up Study
     Ki-Su Kim, Hye-Gyeong Son, Nam-Soo Hong, Duk‐Hee Lee · 2012 · Journal of Preventive Medicine and Public Health
114. Discovery and characterization of a novel non-competitive inhibitor of the divalent metal transporter DMT1/SLC11A2
     Nicolás Montalbetti, Alexandre Simonin, Céline Simonin, Mahendra Awale, Jean‐Louis Reymond, Matthias A. Hediger · 2015 · Biochemical Pharmacology
115. Recombinant Expression and Functional Characterization of Human Hephaestin: A Multicopper Oxidase with Ferroxidase Activity
     Tanya A. M. Griffiths, A. Grant Mauk, Ross T. A. MacGillivray · 2005 · Biochemistry
116. Oxidation of Low-Density Lipoprotein by Iron at Lysosomal pH: Implications for Atherosclerosis
     Leanne Satchell, David S. Leake · 2012 · Biochemistry
117. Discovery of benzylisothioureas as potent divalent metal transporter 1 (DMT1) inhibitors
     Zaihui Zhang, Kodumuru Vishnumurthy, Serguei Sviridov, Shifeng Liu, Mikhail Ayratovich Chafeev, Sultan Chowdhury, Nagasree Chakka, Jianyu Sun, Simon J. Gauthier, Maryanne Mattice et al. · 2012 · Bioorganic & Medicinal Chemistry Letters
118. Premature Atherosclerosis in Children With β-Thalassemia Major
     Orhan Gürsel, Ahmet Emin Kürekçi, Emre Taşçılar, Talia İleri, Demet Altun, Serkan Tapan, İsmail Kurt, Murat Kocaoğlu, Ahmet Aydın, Vedat Okutan et al. · 2012 · Journal of Pediatric Hematology/Oncology
119. Ebselen Decreases Oxygen Free Radical Production and Iron Concentrations in the Hearts of Chronically Iron-Overloaded Mice
     Matthew T. Davis, Wally J. Bartfay · 2004 · Biological Research For Nursing
120. Neogenin Facilitates the Induction of Hepcidin Expression by Hemojuvelin in the Liver
     Ningning Zhao, Julia E. Maxson, Richard H. Zhang, Mastura Wahedi, Caroline A. Enns, An‐Sheng Zhang · 2016 · Journal of Biological Chemistry
121. Transforming Growth Factor β1 (TGF-β1) Activates Hepcidin mRNA Expression in Hepatocytes
     Simeng Chen, Teng Feng, Maja Vujić Spasić, Sandro Altamura, Katja Breitkopf‐Heinlein, Jutta Altenöder, Thomas S. Weiß, Steven Dooley, Martina Ulrike Muckenthaler · 2016 · Journal of Biological Chemistry
122. Heme Exporter FLVCR Is Required for T Cell Development and Peripheral Survival
     Mary Philip, Scott A. Funkhouser, Edison Y. Chiu, Susan R. Phelps, Jeffrey J. Delrow, James Eric Cox, Pamela J. Fink, Janis L. Abkowitz · 2015 · The Journal of Immunology
123. Abnormalities in Iron Metabolism in Multiple Sclerosis
     LESLIE S. VALBERG, Peter R. Flanagan, Ann E. Kertesz, George C. Ebers · 1989 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
124. AG490: An inhibitor of hepcidin expression<i>in vivo</i>
     Zhang, Shu-Ping · 2011 · World Journal of Gastroenterology
125. A reappraisal of macrophage polarization in glioblastoma: Histopathological and immunohistochemical findings and review of the literature
     Chiara Mignogna, Francesco Signorelli, Marco Flavio Michele Vismara, Pio Zeppa, Caterina Camastra, Tullio Barni, Giuseppe Donato, Anna Di Vito · 2016 · Pathology - Research and Practice
126. Desferrioxamine in chronic progressive Multiple Sclerosis: a pilot study
     SHARON G. LYNCH, Kathy Peters, Steven M. LeVine · 1996 · Multiple Sclerosis Journal
127. Dietary Iron and Colorectal Cancer Risk: A Review of Human Population Studies
     Joseph H. Ashmore, Connie Jo Rogers, Shannon L. Kelleher, Samuel M. Lesko, Terryl J. Hartman · 2015 · Critical Reviews in Food Science and Nutrition
128. Small molecule inhibitors of divalent metal transporter-1
     Peter D. Buckett, Marianne Wessling‐Resnick · 2009 · American Journal of Physiology-Gastrointestinal and Liver Physiology
129. Arthropathy in juvenile hemochromatosis
     George Vaiopoulos, George V. Papanikolaou, Marianna Politou, Iyad Jibreel, Nikos Sakellaropoulos, Dimitris Loukopoulos · 2003 · Arthritis & Rheumatism
130. Apolipoprotein E −/− Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function
     Niyati U. Mehta, Victor R. Grijalva, Susan Y. Hama, Alan C. Wagner, Mohamad Navab, Alan M. Fogelman, Srinivasa T. Reddy · 2016 · Arteriosclerosis Thrombosis and Vascular Biology
131. LY2928057, An Antibody Targeting Ferroportin, Is a Potent Inhibitor Of Hepcidin Activity and Increases Iron Mobilization In Normal Cynomolgus Monkeys
     Witcher, Derrick R, Leung, Donmienne, Hill, Karen A, De Rosa, David C, Xu, Jianghuai, Manetta, Joseph, Wroblewski, Victor J, Benschop, Robert J · 2013 · Blood
132. Genetic upregulation of matriptase‐2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation
     Andrew James Sanders, Christian Parr, Tracey Amanda Martin, Jane Lane, Malcolm David Mason, Wen G. Jiang · 2008 · Journal of Cellular Physiology
133. Characterization of the ferritin receptors of human T lymphoid (MOLT-4) cells.
     Dennis Moss, Lawrie W. Powell, Paolo Arosio, June W. Halliday · 1992 · PubMed
134. Pharmacological Characterization of ZYAN1, a Novel Prolyl Hydroxylase Inhibitor for the Treatment of Anemia
     Mukul Rameshchandra Jain, Amit Arvind Joharapurkar, Vrajesh B. Pandya, VISHAL G. PATEL, J. Joshi, Samadhan Govind Kshirsagar, K. Patel, P. Patel, R. Desai · 2015 · Drug Research
135. Targeting the Hepcidin Pathway with RNAi Therapeutics for the Treatment of Anemia
     Akin Akinc, Amy Chan-Daniels, Alfica Sehgal, Don Foster, Brian R. Bettencourt, Julia L. Hettinger, Tim Racie, Justin Aubin, Satya Kuchimanchi, Hila Epstein-Barash et al. · 2011 · Blood
136. Changes in skeletal muscle iron metabolism outpace amyotrophic lateral sclerosis onset in transgenic rats bearing the G93A hmSOD1 gene mutation
     Małgorzata Hałoń, Jan Jacek Kaczor, Wiesław Ziółkowski, Damian Józef Flis, Andżelika Borkowska, Urszula Popowska, Walenty Michał Nyka, Michał Woźniak, Jędrzej Antosiewicz · 2014 · Free Radical Research
137. En Route to New Therapeutic Options for Iron Overload Diseases: Matriptase‐2 as a Target for Kunitz‐Type Inhibitors
     Anna‐Madeleine Beckmann, Eva Maurer, Verena Lülsdorff, Annika Wilms, Norbert Furtmann, Jürgen Bajorath, Michael Gütschow, Marit Stirnberg · 2016 · ChemBioChem
138. A novel oral iron-complex formulation: Encapsulation of hemin in polymeric micelles and its in vitro absorption
     Kimberley Span, Johan J. F. Verhoef, Hedi Hunt, Cornelus F. van Nostrum, Vera Brinks, Huub Schellekens, Wim E. Hennink · 2016 · European Journal of Pharmaceutics and Biopharmaceutics
139. Progressive Reactive Lymphoid Connective Tissue Disease and Development of Autoantibodies in Scavenger Receptor A5–Deficient Mice
     Juha Risto Matias Ojala, Timo Pikkarainen, Göran Elmberger, Karl Tryggvason · 2013 · American Journal Of Pathology
140. Mutations in FLVCR2 associated with Fowler syndrome and survival beyond infancy
     Malin Kvarnung, Fulya Taylan, Daniel Nilsson, Margareta Albåge, Magnus Nordenskjöld, Britt‐Marie Anderlid, Ann Nordgren, Elisabeth Syk Lundberg · 2015 · Clinical Genetics
141. FLVCR is necessary for erythroid maturation, may contribute to platelet maturation, but is dispensable for normal hematopoietic stem cell function
     John Chong Han Byon, Jing Chen, Raymond T. Doty, Janis L. Abkowitz · 2013 · Blood
142. Structure and metal ion binding of the first transmembrane domain of DMT1
     Dan Wang, Yuande Song, Jiantao Li, Chunyu Wang, Fei Li · 2010 · Biochimica et Biophysica Acta (BBA) - Biomembranes
143. The small molecule ferristatin II induces hepatic hepcidin expression in vivo and in vitro
     Ahmed A. Alkhateeb, Peter D. Buckett, Andrew M. Gardeck, Jonghan Kim, Shaina L. Byrne, Paula Goodman Fraenkel, Marianne Wessling‐Resnick · 2015 · American Journal of Physiology-Gastrointestinal and Liver Physiology
144. Delivery of Oligoribonucleotides to Human Hepatoma Cells Using Cationic Lipid Particles Conjugated to Ferric Protoporphyrin IX (Heme)
     Garry Β. Takle, Alain Roger Thierry, Sandra Flynn, BO PENG, LISA WHITE, Wayne Devonish, Richard A. Galbraith, Allan R. Goldberg, Shaji T. George · 1997 · Antisense and Nucleic Acid Drug Development
145. Inhibition of iron uptake by ferristatin II is exerted through internalization of DMT1 at the plasma membrane
     Izumi Yanatori, Yumiko Yasui, Yumiko Noguchi, Fumio Kishi · 2014 · Cell Biology International
146. Development of hematin conjugated PLGA nanoparticle for selective cancer targeting
     Md. Lutful Amin, Dami Kim, SeJin Kim · 2016 · European Journal of Pharmaceutical Sciences
147. Insights into Matriptase‐2 Substrate Binding and Inhibition Mechanisms by Analyzing Active‐Site‐Mutated Variants
     Eva Maurer, Mihiret T. Sisay, Marit Stirnberg, Torsten Steinmetzer, Jürgen Bajorath, Michael Gütschow · 2011 · ChemMedChem
148. Energetics of ligand-receptor binding affinity on endothelial cells: An in vitro model
     Iolanda Fotticchia, Daniela Guarnieri, Teresa Fotticchia, Andrea Patrizia Falanga, Raffaele Vecchione, Concetta Giancola, Paolo A. Netti · 2016 · Colloids and Surfaces B Biointerfaces
149. Human STEAP3 mutations with no phenotypic red cell changes
     Dun Liu, Sheng Yi, Xinhua Zhang, Ping Fang, Chenguang Zheng, Li Lin, Ren Cai, Yuhua Ye, Yuqiu Zhou, Yunhao Liang et al. · 2015 · Blood
150. Low expression of ferroxidases is implicated in the iron retention in human atherosclerotic plaques
     Jiajie Ji, Yu Zhou, Shuangying Hao, Qi Wang, Kuanyu Li, Tong Qiao · 2015 · Biochemical and Biophysical Research Communications
151. Phase 1 study of a hepcidin antagonist, LY2787106, in cancer-associated anemia
     Vadhan-Raj, Saroj, Abonour, Rafat, Goldman, Jonathan W., Smith, David A., Slapak, Christopher A., Tiu, Ramon V., Wang, Xuejing, Callies, Sophie, Cox, Joanne, Tuttle, Jay L. et al. · 2015 · Blood
152. A Possible Role Of The Tetraspanin CD9 In Bone Marrow Retention and Engraftment Of Human CD34+ Hematopoietic Stem/Progenitor Cells
     Kam Tong Leung, Karen Li, Kam Sze Tsang, Kathy Yuen Yee Chan, Pak Cheung Ng, Chi Kong Li · 2013 · Blood
153. FP380JTZ-951, AN ORAL NOVEL HIF-PHD INHIBITOR, ELEVATES HEMOGLOBIN IN JAPANESE ANEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE NOT ON DIALYSIS
     Tadao Akizawa, Koji Hanaki, Masanobu Arai · 2015 · Nephrology Dialysis Transplantation